FEDERAL · 21 CFR

§ 860.1-860 — Not Yet Available

21 C.F.R. § 860.1-860

21 C.F.R. § 860.1-860 is referenced in other legal documents but could not be loaded from the eCFR.

This section may have been removed, reserved, or renumbered. Browse Part 860 or Title 21 — Food and Drugs for available sections.

Nearby Sections

15

§ 860.1

§ 860.3

§ 860.5

Confidentiality and use of data and information submitted in connection with classification and reclassification.

§ 860.7

Determination of safety and effectiveness.

§ 860.10

Implants and life-supporting or life-sustaining devices.

§ 860.15

Exemptions from sections 510, 519, and 520(f) of the Federal Food, Drug, and Cosmetic Act.

§ 860.84

Classification procedures for “preamendments devices.”

§ 860.90

Consultation with panels.

§ 860.120

§ 860.123

Reclassification petition: Content and form.

§ 860.125

Consultation with panels.

§ 860.130

General procedures under section 513(e) of the Federal Food, Drug, and Cosmetic Act.

§ 860.132

Procedures when the Commissioner initiates a performance standard or premarket approval proceeding under section 514(b) or 515(b) of the Federal Food, Drug, and Cosmetic Act.

§ 860.133

Procedures when the Commissioner initiates a proceeding to require premarket approval under section 515(b) of the Federal Food, Drug, and Cosmetic Act.

§ 860.134

Procedures for reclassification of “postamendments devices” under section 513(f)(3) of the Federal Food, Drug, and Cosmetic Act.